REGENERON PHARMACEUTICALS, INC.
REGNPharmaceutical Preparations · SIC 2834 · CIK 0000872589
Revenue FY2025
$14.34B
Net Income
$4.51B
EPS (Basic)
$43.07
Net Margin
31.4%
ROE
14.4%
Total Equity
$31.26B
Shares Out
94M
REGENERON PHARMACEUTICALS, INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2008–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 8 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Southeastern Asset Management
Mason Hawkins
$0.09B
2.6%
+16.6%
Sound Shore Management
Harry Burn
$0.08B
2.3%
(15.9%)
Dodge & Cox
Dodge & Cox
$3.04B
0.7%
+9.3%
Renaissance Technologies
Renaissance Technologies
$0.09B
0.1%
+121.9%
Adage Capital Management
Adage Capital Management
$0.05B
0.1%
(18.9%)
Capital World Investors
Capital World Investors
$0.51B
0.1%
(42.6%)
Bridgewater Associates
Bridgewater Associates
$0.03B
0.0%
+125.9%
Alps Advisors
Alps Advisors
$0.00B
0.0%
+175.9%
Insider Transactions
Reading stored insider transactions…